But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

For decades, the standard treatment for these potentially ... the world have experienced eosinophilic asthma or COPD flare-up. Under current best treatments, 30 of them will require further ...

COPD is the third leading cause of death worldwide ... we'll make sure that families everywhere never face a lung condition without the best treatment and care." More information: Monoclonal ...

If you're not paying close attention, the first stage can be easy to miss. COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

And according to the WHO, COPD is the fourth leading cause of death ... “WIN378, with its best-in-class potential to provide ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

He said ensifentrine will "change the treatment paradigm" for COPD by providing bronchodilation and anti-inflammatory properties in one compound. In both studies, it was administered on top of ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.